Skip to content

Turkish Nationwide SurvEy of Glycemic and Other Metabolic Parameters of Patients With Diabetes Mellitus

Turkish Nationwide SurvEy of Glycemic and Other Metabolic Parameters of Patients With Diabetes Mellitus (TEMD Study)

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03455101
Acronym
TEMD
Enrollment
5240
Registered
2018-03-06
Start date
2017-04-01
Completion date
2017-06-30
Last updated
2018-03-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Mellitus

Keywords

Cardiovascular risk status, Optimal metabolic control

Brief summary

This study evaluates the overall cardiovascular risk status and best predictors of optimal metabolic control of Turkish adult patients with diabetes mellitus.

Detailed description

Diabetes mellitus is one of the most common chronic diseases with an increasing prevalence worldwide.The prevalence of diabetes is also increased significantly in Turkey, from 7.2 % in 2002 to 13.7% in 2012.This increasing prevalence leads to serious public health problems and a significant economic burden. Therefore, the optimal treatment of diabetes and prevention of diabetic complications, especially the cardiovascular outcomes, is utmost important. Although achieving glycemic targets in patients with diabetes is of great importance, blood glucose is not the only predictor of cardiovascular outcome in diabetes. Optimization of other metabolic parameters such as lipids, arterial blood pressure (ABP), and body weight as well as a healthy lifestyle are utmost important. As there is hardly enough data about glycemic and other metabolic control parameters in Turkish adult patients with type 1 or type 2 diabetes, this nationwide survey was performed.

Interventions

There is no intervention.

Sponsors

Gulhane School of Medicine
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients with type 1 or type 2 diabetes * Upper than 18 years old * To be under follow-up in the same center for at least one year.

Exclusion criteria

* Pregnancy * Younger than 18 years old, * History of decompensated liver disease, * History of psychiatric disorders interfering cognition or compliance * History of bariatric surgery * History of renal replacement therapy.

Design outcomes

Primary

MeasureTime frameDescription
Glycemia control status of Turkish adult patients with diabetes mellitus7 daysGlycemia control will be defined as good control if the mean HbA1c level of patients \< 7% or poor control if the mean HbA1c level of patient \> 7%

Secondary

MeasureTime frameDescription
Blood pressure control status of Turkish adult patients with diabetes mellitus7 daysHome blood pressure \<135/85 mmHg will be defined as under control.
Lipid control status of Turkish adult patients with diabetes mellitus.7 days.Triglyceride \< 150 mg/dl, LDL-C \< 100 mg/dl, HDL-C \> 40 mg/dl for men, and HDL-C \> 50 mg/dl for women will be defined as under control.
Weight control status of Turkish adult patients with diabetes mellitus.7 days.Body mass index \< 30 kg/m2 will be defined as under control. Weight and height will be combined to report body mass index in kg/m2.

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 19, 2026